Literature DB >> 35693671

Bone Mineral Density and Body Composition in Males with Motor Neuron Disease: A Study from Teaching Hospital in Southern Part of India.

Mahmood D Al-Mendalawi1.   

Abstract

Entities:  

Year:  2022        PMID: 35693671      PMCID: PMC9175416          DOI: 10.4103/aian.aian_386_21

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.714


× No keyword cloud information.
Sir, Sooragonda et al.[1] assessed bone mineral density (BMD), bone mineral parameters, and body composition in Indian patients with motor neuron disease – amyotrophic lateral sclerosis (MND-ALS) – and compared these with healthy controls. They found that MND-ALS patients and healthy controls had similar BMDs [as measured by Dual-energy X-ray absorptiometry (DXA) scan]. However, bone turnover markers (BTMs) were significantly higher in the MND-ALS group, indicating a high turnover state.[1] Accordingly, they recommended testing for serum calcium, 25-hydroxy vitamin D, BTMs, and BMD in MND-ALS patients.[1] Besides few study limitations mentioned by Sooragonda et al.,[1] I presume that the following methodological limitation is also relevant. It is obvious that BMD reference intervals (BMDRIs) are required to interpret BMD estimates measured by DXA scan. BMDRIs are determined by many factors, namely age, gender, race, weight, pubertal stage, and socio-economic class,[23] and normative BMDRIs have been generated for certain populations. These normative BMDRIs are utilized in clinical settings and researchcenters. Interestingly, India has already constructed its indigenous BMDRIs.[4] Instead of employing Indian normative BMDRIs, Sooragonda et al.[1] have inadvertently employed the International Society of Clinical Densitometry (ISCD) criteria released in 2004[5] to define osteoporosis and normal BMD on interpreting the calculated BMD values. We feel that this limitation in their methodology might affect the interpretation of the study findings and recommendations addressed by Sooragonda et al.[1] It was solicited from Sooragonda et al.[1] to add in the limitations of their study that they could not employ the new Indian reference data, released in 2021,[4] as it was not launched at the time of conducting their study. The data in the Indian BMDRIs was recruited from a limited number of subjects (825 subjects: men = 380; women = 445)[4] and needs further substantiation. Hence, they have used international criteria.[5]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  5 in total

1.  Age, race, weight, and gender impact normative values of bone mineral density.

Authors:  Qing Wu; John J Lefante; Janet C Rice; Jeanette H Magnus
Journal:  Gend Med       Date:  2011-06

2.  Bone mineral density by age, gender, pubertal stages, and socioeconomic status in healthy Lebanese children and adolescents.

Authors:  Asma Arabi; Mona Nabulsi; Joyce Maalouf; Mahmoud Choucair; Hassan Khalifé; Reinhold Vieth; Ghada El-Hajj Fuleihan
Journal:  Bone       Date:  2004-11       Impact factor: 4.398

3.  Bone mineral density in healthy adult Indian population: the Chandigarh Urban Bone Epidemiological Study (CUBES).

Authors:  Anshita Aggarwal; Rimesh Pal; Sanjay Kumar Bhadada; Sant Ram; Abhilasha Garg; Anil Bhansali; Priyanka Singh; J S Thakur; Tulika Singh; Naresh Sachdeva; Sudhaker D Rao
Journal:  Arch Osteoporos       Date:  2021-01-21       Impact factor: 2.617

Review 4.  Position statement : executive summary. The Writing Group for the International Society for Clinical Densitometry (ISCD) Position Development Conference.

Authors: 
Journal:  J Clin Densitom       Date:  2004       Impact factor: 2.963

5.  Bone Mineral Density and Body Composition in Males with Motor Neuron Disease: A Study from Teaching Hospital in Southern Part of India.

Authors:  Basavaraj G Sooragonda; Sandeep Agarwal; Rohit Ninan Benjamin; A T Prabhakar; Ajith Sivadasan; Nitin Kapoor; Kripa E Cherian; Felix K Jebasingh; Sanjith Aaron; Nihal Thomas; Vivek Mathew; Hesarghatta S Asha; Thomas V Paul
Journal:  Ann Indian Acad Neurol       Date:  2020-08-28       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.